Synthetic DNA-delivered antibodies protect against Ebola in preclinical studies
Scientists at The Wistar Institute and collaborators have successfully engineered novel DNA-encoded monoclonal antibodies (DMAbs) targeting Zaire Ebolavirus that were effective in preclinical models. Study results, published ...
Nov 13, 2018
0
58